Biofrontera Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.1%.

Top 19 shareholders own 49.22% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
29.3%	Biofrontera AG	400,000	€3.3m	0%	no data
11.5%	Abshagen-Consulting Gmbh	157,402	€1.3m	0%	no data
4.31%	Deutsche Balaton AG	58,884	€488.5k	0%	0.2%
0.8%	The Vanguard Group, Inc.	10,952	€90.9k	0%	no data
0.76%	Hermann Luebbert	10,440	€86.6k	84.2%	no data
0.7%	Bard Associates Inc.	9,560	€79.3k	-3.53%	0.04%
0.49%	Erica Monaco	6,651	€55.2k	135%	no data
0.34%	BlackRock, Inc.	4,621	€38.3k	-29.9%	no data
0.32%	Schonfeld Strategic Advisors LLC	4,425	€36.7k	-0.45%	no data
0.3%	Geode Capital Management, LLC	4,064	€33.7k	-2.17%	no data
0.18%	Renaissance Technologies LLC	2,521	€20.9k	41.2%	no data
0.084%	State Street Global Advisors, Inc.	1,145	€9.5k	0%	no data
0.076%	Northern Trust Global Investments	1,036	€8.6k	0%	no data
0.048%	Tower Research Capital LLC	655	€5.4k	-0.91%	no data
0.042%	Woodbury Financial Services, Inc, Securities Investments	575	€4.8k	0%	no data
0.01%	Osaic Wealth, Inc. , Asset Management Arm	137	€1.1k	0%	no data
0.00073%	Royal Bank of Canada, Banking & Securities Investments	10	€82.8	-9.09%	no data
0.00044%	Wells Fargo & Company, Private Banking and Investment Banking Arm	6	€49.9	0%	no data
0.00022%	Simplex Trading, LLC, Asset Management Arm	3	€25.0	0%	no data